Company news

Share this article:
Cypress Pharmaceutical has entered into a multiple generic product development and marketing agreement with Standard Chem. & Pharm. Under the terms of the deal, Standard Chem. & Pharm. has the exclusive development and manufacturing rights and Cypress Pharmaceutical, Inc. has exclusive US marketing rights of generic drug products. Other financial terms of the agreement have not been disclosed.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.